369 related articles for article (PubMed ID: 6138646)
21. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo reversal of thyroid epithelial polarity: its relevance for autoimmune thyroid disease.
Hanafusa T; Pujol-Borrell R; Chiovato L; Doniach D; Bottazzo GF
Clin Exp Immunol; 1984 Sep; 57(3):639-46. PubMed ID: 6380840
[TBL] [Abstract][Full Text] [Related]
23. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
[No Abstract] [Full Text] [Related]
24. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
[TBL] [Abstract][Full Text] [Related]
25. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
[TBL] [Abstract][Full Text] [Related]
26. Up-regulated beta1-integrin expression in autoimmune thyroid disorders.
Marazuela M; De Landázuri MO; Larrañaga E; Sánchez-Madrid F
Clin Exp Immunol; 1997 Jul; 109(1):107-15. PubMed ID: 9218832
[TBL] [Abstract][Full Text] [Related]
27. The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis.
Weetman AP; Volkman DJ; Burman KD; Margolick JB; Petrick P; Weintraub BD; Fauci AS
Clin Immunol Immunopathol; 1986 Apr; 39(1):139-50. PubMed ID: 3485022
[TBL] [Abstract][Full Text] [Related]
28. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.
Martin A; Goldsmith NK; Friedman EW; Schwartz AE; Davies TF; Roman SH
Autoimmunity; 1990; 6(4):269-81. PubMed ID: 1716476
[TBL] [Abstract][Full Text] [Related]
29. [Intrathyroidal T cell activation and HLA-DR antigen expression on thyroid follicular cells in autoimmune thyroid diseases].
Wang J
Zhonghua Yi Xue Za Zhi; 1992 Feb; 72(2):77-80, 127. PubMed ID: 1327436
[TBL] [Abstract][Full Text] [Related]
30. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells.
Londei M; Bottazzo GF; Feldmann M
Science; 1985 Apr; 228(4695):85-9. PubMed ID: 3871967
[TBL] [Abstract][Full Text] [Related]
31. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
32. HLA-DP, DQ and DR gene expression in Graves' disease and normal thyroid epithelium.
Piccinini LA; Goldsmith NK; Roman SH; Davies TF
Tissue Antigens; 1987 Oct; 30(4):145-54. PubMed ID: 3120348
[TBL] [Abstract][Full Text] [Related]
33. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
[TBL] [Abstract][Full Text] [Related]
34. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease.
Hamilton F; Black M; Farquharson MA; Stewart C; Foulis AK
Clin Exp Immunol; 1991 Jan; 83(1):64-8. PubMed ID: 1899065
[TBL] [Abstract][Full Text] [Related]
35. Function of DR-positive thyrocytes from patients with Graves' disease: quantitative analysis of thyroid peroxidase content by fluorescent photometry.
Asakawa H; Hanafusa T; Kuma K; Kono N; Tarui S
J Clin Endocrinol Metab; 1992 Mar; 74(3):614-8. PubMed ID: 1740495
[TBL] [Abstract][Full Text] [Related]
36. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
37. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
38. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
[TBL] [Abstract][Full Text] [Related]
39. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.
Mölne J; Jansson S; Ericson LE; Nilsson M
Autoimmunity; 1994; 17(1):59-71. PubMed ID: 8025214
[TBL] [Abstract][Full Text] [Related]
40. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
